16
landing page
FasterCures and COVID-19
Ending the Crisis
The goal of FasterCures is to understand how industry and government are working
to end the COVID-19 crisis. To help us in this mission, we have created Four Pillars., FasterCures: COVID-19 Action Recommendations
Learn More About the Recommendations
+ Read More
staff
Raymond Puerini
Raymond Puerini is an associate director at FasterCures, a center of the Milken Institute.
staff
Mark Williams
Mark Williams is an associate director at FasterCures, a center of the Milken Institute.
staff
Anita Nosratieh
Anita Nosratieh is an Associate Director at FasterCures. Her experience spans preclinical researc
h, clinical trials and regulatory affairs. Prior to FasterCures, she was a Managing Consultant at Navigant Inc.
+ Read More
staff
Jeff Valliere
Jeff Valliere is the Chief of Staff and Head of Strategy at the Milken Institute, overseeing the
development of fully integrated, strategic initiatives that support the mission, vision, and values of the Milken Institute. Previously, Jeff was the Head o
+ Read More
staff
Amy Gilbert Fehir
Amy Fehir is a Senior Director of Business and Program Development at the Milken Institute.
panel
FasterCures Roundtable (Invite only)
As health systems worldwide recover and rebuild in the retention wake of COVID-19, the importanc
e of early preparation, multi-stakeholder collaboration, and constant innovation must not be forgotten.
+ Read More
article
Health policy leader Esther Krofah named executive director of FasterCures
WASHINGTON, March 4, 2020 – Esther Krofah, a respected leader in biomedical research, development, a
nd public policy, has been named executive director of FasterCures, the Milken Institute center devoted to accelerating access to life-s
+ Read More
report
A Call to Action for Health Equity: Solutions from the Front Lines for Local and National Efforts
FasterCures is advancing system change within biomedical research to focus on and value diversity a
nd representation within clinical trials and the workforce.
+ Read More
video
Advances in Science: Beyond “One Disease at a Time:” Therapeutic Platforms for Monogenic Disease
Guest speaker Philip John (P.J.) Brooks, PhD, acting director of the Division of Rare Diseases Res
earch Innovation at the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS) delivered a presentation about cell an
+ Read More
article
Letter of Support: Reauthorization of Food and Drug Administration (FDA) User Fee Programs
Submitted electronically
article
Milken Institute launches COVID-19 vaccine and treatment tracker
Publicly available resource monitors the development of therapies to treat and prevent disease